$ALPXR
Alpex Acquisition Corp
CIK:0002125551|SEC Filings
Unaudited Condensed Statements of Cash Flows |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
USD ($)
| |
| Cash Flows from Operating Activities: | |
| Net loss | $ (183,244) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Formation and operating costs paid by Sponsor | 92,925 |
| Deferred offering cost written off to expense | 5,000 |
| Income earned on cash and Cash and marketable securities held in trust account | (32,370) |
| Changes in operating assets and liabilities: | |
| Accrued liabilities and other payables | 18,959 |
| Prepaid expenses | (120,000) |
| Net cash used in operating activities | (218,730) |
| Cash Flows from Investing Activities: | |
| Investment of cash in trust account | (115,000,000) |
| Net cash used in investing activities | (115,000,000) |
| Cash Flows from Financing Activities: | |
| Capital contribution from Sponsor | 1,000 |
| Proceeds from public offering | 115,000,000 |
| Cash proceeds from private placement | 1,800,000 |
| Payment of offering costs | (827,318) |
| Net cash provided by financing activities | 115,973,682 |
| Net increase in cash and cash equivalents | 754,952 |
| Cash and cash equivalents at beginning of period | |
| Cash and cash equivalents at end of period | 754,952 |
| Supplemental disclosure of non-cash financing activities: | |
| Deferred offering costs paid by Sponsor and included in Promissory Note | 226,103 |
| Deferred underwriting fee accrued and charged to additional paid-in capital | 805,000 |
| Private placement and founder share subscription amounts settled against Promissory Note | 100,000 |
| Representative shares issued as non-cash underwriting compensation | $ 251,713 |
Condensed Balance Sheets - USD ($) |
Jun. 30, 2026 |
Mar. 15, 2025 |
||||
|---|---|---|---|---|---|---|
| Current assets: | ||||||
| Cash and cash equivalents | $ 754,952 | |||||
| Prepaid expenses | 120,000 | |||||
| Deferred offering costs | 117,000 | |||||
| Total current assets | 874,952 | 117,000 | ||||
| Cash and marketable securities held in trust account | 115,032,370 | |||||
| Total assets | 115,907,322 | 117,000 | ||||
| Current liabilities: | ||||||
| Accrued expenses and other current liabilities | 18,959 | |||||
| Promissory note - related party | 219,028 | 170,102 | ||||
| Total current liabilities | 237,987 | 170,102 | ||||
| Deferred underwriting fee payable | 805,000 | |||||
| Total liabilities | 1,042,987 | 170,102 | ||||
| Commitments and Contingencies | ||||||
| Shareholders’ Deficit: | ||||||
| Preferred shares, $0.0001 par value; 10,000,000 shares authorized; none issued and outstanding | ||||||
| Additional paid-in capital | 14,879 | 24,712 | ||||
| Share subscription receivable | (25,000) | |||||
| Accumulated deficit | (183,244) | (53,102) | ||||
| Total Shareholders’ Deficit | (168,035) | (53,102) | ||||
| Total Liabilities and Shareholders’ Deficit | 115,907,322 | 117,000 | ||||
| Class A Ordinary Shares | ||||||
| Current liabilities: | ||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 11,500,000 shares at initial redemption value of $10.00 per share, as adjusted for Trust Account earnings | 115,032,370 | |||||
| Shareholders’ Deficit: | ||||||
| Ordinary shares, value | [1] | 42 | ||||
| Class B Ordinary Shares | ||||||
| Shareholders’ Deficit: | ||||||
| Ordinary shares, value | [2] | $ 288 | $ 288 | |||
| ||||||